Postmenopausal endometriosis: a challenging condition beyond menopause.
Journal
Menopause (New York, N.Y.)
ISSN: 1530-0374
Titre abrégé: Menopause
Pays: United States
ID NLM: 9433353
Informations de publication
Date de publication:
25 Mar 2024
25 Mar 2024
Historique:
medline:
26
3
2024
pubmed:
26
3
2024
entrez:
26
3
2024
Statut:
aheadofprint
Résumé
Postmenopausal endometriosis is a complex condition that challenges the conventional belief that endometriosis resolves with menopause. Despite the cessation of menstruation, a subset of women continues to experience or develop endometriosis-related symptoms during the postmenopausal period. Thus, this review aimed to shed light on postmenopausal endometriosis, exploring its clinical features, diagnostic considerations, management approaches, and the potential impact on women's health. PubMed/Medline, Scopus, and Web of Science databases were used for the research, with only articles in English language, using the following terms: "postmenopausal endometriosis," "menopause," "management," "treatment," and "quality of life," from inception to 2023. The clinical features of postmenopausal endometriosis include persistent or recurrent pelvic pain, dyspareunia, bowel, or urinary symptoms and, occasionally, abnormal vaginal bleeding. The absence of menstrual cycles presents a diagnostic challenge, as the traditional diagnostic criteria for endometriosis rely on menstrual patterns. Visual cues may be less evident, and the symptoms often overlap with other gynecological conditions, necessitating a thorough evaluation to differentiate postmenopausal endometriosis from other potential causes. Management approaches for postmenopausal endometriosis encompass surgical intervention, hormonal therapies, pain management, and individualized care. Postmenopausal endometriosis significantly impacts the quality of life, sexual health, and long-term well-being of women. Understanding the clinical features, diagnostic challenges, and management approaches of postmenopausal endometriosis is crucial for healthcare professionals to provide effective care and to improve the quality of life of women affected by this condition.
Identifiants
pubmed: 38531006
doi: 10.1097/GME.0000000000002338
pii: 00042192-990000000-00301
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 by The Menopause Society.
Déclaration de conflit d'intérêts
Financial disclosure/conflicts of interest: None reported.
Références
Streuli I, Gaitzsch H, Wenger J-M, Petignat P. Endometriosis after menopause: physiopathology and management of an uncommon condition. Climacteric 2017;20:138–143. doi: 10.1080/13697137.2017.1284781
doi: 10.1080/13697137.2017.1284781
Secosan C, Balulescu L, Brasoveanu S, et al. Endometriosis in menopause—renewed attention on a controversial disease. Diagnostics 2020;10:134. doi: 10.3390/diagnostics10030134
doi: 10.3390/diagnostics10030134
Mehedintu C, Plotogea M, Ionescu S, Antonovici M. Endometriosis still a challenge. J Med Life 2014;7:349–357.
Oxholm D, Knudsen UB, Kryger-Baggesen N, Ravn P. Postmenopausal endometriosis. Acta Obstet Gynecol Scand 2007;86:1158–1164. doi: 10.1080/00016340701619407
doi: 10.1080/00016340701619407
Parasar P, Ozcan P, Terry KL. Endometriosis: epidemiology, diagnosis and clinical management. Curr Obstet Gynecol Rep 2017;6:34–41. doi: 10.1007/s13669-017-0187-1
doi: 10.1007/s13669-017-0187-1
Vallée A, Ceccaldi P-F, Carbonnel M, Feki A, Ayoubi J-M. Pollution and endometriosis: a deep dive into the environmental impacts on women's health. BJOG 2024;131:401–414. doi: 10.1111/1471-0528.17687
doi: 10.1111/1471-0528.17687
Bulletti C, Coccia ME, Battistoni S, Borini A. Endometriosis and infertility. J Assist Reprod Genet 2010;27:441–447. doi: 10.1007/s10815-010-9436-1
doi: 10.1007/s10815-010-9436-1
Dalal PK, Agarwal M. Postmenopausal syndrome. Indian J Psychiatry 2015;57:S222–S232. doi: 10.4103/0019-5545.161483
doi: 10.4103/0019-5545.161483
Harper JC, Phillips S, Biswakarma R, et al. An online survey of perimenopausal women to determine their attitudes and knowledge of the menopause. Womens Health (Lond) 2022;18:17455057221106890. doi: 10.1177/17455057221106890
doi: 10.1177/17455057221106890
Leidy LE. Biological aspects of menopause: across the lifespan. Ann Rev Anthropol 1994;23:231–253. doi: 10.1146/annurev.an.23.100194.001311
doi: 10.1146/annurev.an.23.100194.001311
Brosens I, Benagiano G. Endometriosis, a modern syndrome. Indian J Med Res 2011;133:581–593.
Bendon CL, Becker CM. Potential mechanisms of postmenopausal endometriosis. Maturitas 2012;72:214–219. doi: 10.1016/j.maturitas.2012.04.010
doi: 10.1016/j.maturitas.2012.04.010
de Almeida Asencio F, Ribeiro HA, Ayrosa Ribeiro P, et al. Symptomatic endometriosis developing several years after menopause in the absence of increased circulating estrogen concentrations: a systematic review and seven case reports. Gynecol Surg 2019;16:3. doi: 10.1186/s10397-019-1056-x
doi: 10.1186/s10397-019-1056-x
Koninckx PR, Ussia A, Adamyan L, Wattiez A, Gomel V, Martin DC. Pathogenesis of endometriosis: the genetic/epigenetic theory. Fertil Steril 2019;111:327–340. doi: 10.1016/j.fertnstert.2018.10.013
doi: 10.1016/j.fertnstert.2018.10.013
Yu K, Huang Z-Y, Xu X-L, Li J, Fu X-W, Deng S-L. Estrogen receptor function: impact on the human endometrium. Front Endocrinol 2022;13:827724. doi: 10.3389/fendo.2022.827724
doi: 10.3389/fendo.2022.827724
Mori T, Ito F, Koshiba A, et al. Local estrogen formation and its regulation in endometriosis. Reprod Med Biol 2019;18:305–311. doi: 10.1002/rmb2.12285
doi: 10.1002/rmb2.12285
Bulun SE, Monsivais D, Kakinuma T, et al. Molecular biology of endometriosis: from aromatase to genomic abnormalities. Semin Reprod Med 2015;33:220–224. doi: 10.1055/s-0035-1554053
doi: 10.1055/s-0035-1554053
Cope AG, VanBuren WM, Sheedy SP. Endometriosis in the postmenopausal female: clinical presentation, imaging features, and management. Abdom Radiol N Y 2020;45:1790–1799. doi: 10.1007/s00261-019-02309-4
doi: 10.1007/s00261-019-02309-4
Hudson QJ, Perricos A, Wenzl R, Yotova I. Challenges in uncovering non-invasive biomarkers of endometriosis. Exp Biol Med 2020;245:437–447. doi: 10.1177/1535370220903270
doi: 10.1177/1535370220903270
Inceboz U. Endometriosis after menopause. Womens Health Lond Engl 2015;11:711–715. doi: 10.2217/whe.15.59
doi: 10.2217/whe.15.59
Collinet P, Fritel X, Revel-Delhom C, et al. Management of endometriosis: CNGOF/HAS clinical practice guidelines — short version. J. Gynecol. Obstet. Hum. Reprod 2018;47:265–274. doi: 10.1016/j.jogoh.2018.06.003
doi: 10.1016/j.jogoh.2018.06.003
Tan DA, Almaria MJG. Postmenopausal endometriosis: drawing a clearer clinical picture. Climacteric 2018;21:249–255. doi: 10.1080/13697137.2018.1450855
doi: 10.1080/13697137.2018.1450855
Henriksen E. Endometriosis. Am J Surg 1955;90:331–337. doi: 10.1016/0002-9610(55)90765-0
doi: 10.1016/0002-9610(55)90765-0
Ranney B. Endometriosis. 3. Complete operations. Reasons, sequelae, treatment. Am J Obstet Gynecol 1971;109:1137–1144. doi: 10.1016/0002-9378(71)90653-3
doi: 10.1016/0002-9378(71)90653-3
Punnonen R, Klemi PJ, Nikkanen V. Postmenopausal endometriosis. Eur J Obstet Gynecol Reprod Biol 1980;11:195–200. doi: 10.1016/0028-2243(80)90069-6
doi: 10.1016/0028-2243(80)90069-6
Nikkanen V, Punnonen R. External endometriosis in 801 operated patients. Acta Obstet Gynecol Scand 1984;63:699–701. doi: 10.3109/00016348409154666
doi: 10.3109/00016348409154666
Haas D, Chvatal R, Reichert B, et al. Endometriosis: a premenopausal disease? Age pattern in 42,079 patients with endometriosis. Arch Gynecol Obstet 2012;286:667–670. doi: 10.1007/s00404-012-2361-z
doi: 10.1007/s00404-012-2361-z
Popoutchi P, dos Reis Lemos CR, Silva JC, Nogueira AA, Feres O, Ribeiro da Rocha JJ. Postmenopausal intestinal obstructive endometriosis: case report and review of the literature. Sao Paulo Med J 2008;126:190–193. doi: 10.1590/s1516-31802008000300010
doi: 10.1590/s1516-31802008000300010
Morotti M, Remorgida V, Venturini PL, Ferrero S. Endometriosis in menopause: a single institution experience. Arch Gynecol Obstet 2012;286:1571–1575. doi: 10.1007/s00404-012-2473-5
doi: 10.1007/s00404-012-2473-5
Bulun SE. Endometriosis. N Engl J Med 2009;360:268–279. doi: 10.1056/NEJMra0804690
doi: 10.1056/NEJMra0804690
Sampson JA. Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol 1927;3:93–110.43.
Kirshon B, Poindexter AN, Fast J. Endometriosis in multiparous women. J Reprod Med 1989;34:215–217.
Bulun SE, Yang S, Fang Z, Gurates B, Tamura M, Sebastian S. Estrogen production and metabolism in endometriosis. Ann. N. Y. Acad. Sci. 2002;955:75–85; discussion 86-88, 396-406. doi: 10.1111/j.1749-6632.2002.tb02767.x
doi: 10.1111/j.1749-6632.2002.tb02767.x
Vimercati A, Achilarre MT, Scardapane A, et al. Accuracy of transvaginal sonography and contrast-enhanced magnetic resonance-colonography for the presurgical staging of deep infiltrating endometriosis. Ultrasound Obstet Gynecol 2012;40:592–603. doi: 10.1002/uog.11179
doi: 10.1002/uog.11179
Liu X, Zhang Q, Guo S-W. Histological and immunohistochemical characterization of the similarity and difference between ovarian endometriomas and deep infiltrating endometriosis. Reprod Sci Thousand Oaks Calif 2018;25:329–340. doi: 10.1177/1933719117718275
doi: 10.1177/1933719117718275
Zhang Q, Dong P, Liu X, Sakuragi N, Guo S-W. Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis. Sci Rep 2017;7:6804. doi: 10.1038/s41598-017-06920-7
doi: 10.1038/s41598-017-06920-7
Nisenblat V, Bossuyt PM, Farquhar C, Johnson N, Hull ML. Imaging modalities for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev 2016;2016:CD009591. doi: 10.1002/14651858.CD009591.pub2
doi: 10.1002/14651858.CD009591.pub2
Hsu AL, Khachikyan I, Stratton P. Invasive and non-invasive methods for the diagnosis of endometriosis. Clin Obstet Gynecol 2010;53:413–419. doi: 10.1097/GRF.0b013e3181db7ce8
doi: 10.1097/GRF.0b013e3181db7ce8
Kao A, Binik YM, Kapuscinski A, Khalifé S. Dyspareunia in postmenopausal women: a critical review. Pain Res Manag J Can Pain Soc 2008;13:243–254. doi: 10.1155/2008/269571
doi: 10.1155/2008/269571
Indrielle-Kelly T, Frühauf F, Fanta M, et al. Diagnostic accuracy of ultrasound and MRI in the mapping of deep pelvic endometriosis using the International Deep Endometriosis Analysis (IDEA) consensus. Biomed Res Int 2020;2020:3583989. doi: 10.1155/2020/3583989
doi: 10.1155/2020/3583989
Zuber M, Shoaib M, Kumari S. Magnetic resonance imaging of endometriosis: a common but often hidden, missed, and misdiagnosed entity. Pol J Radiol 2022;87:e448–e461. doi: 10.5114/pjr.2022.119032
doi: 10.5114/pjr.2022.119032
Becker CM, Bokor A, Heikinheimo O, et al; ESHRE Endometriosis Guideline Group. ESHRE guideline: endometriosis. Hum Reprod Open 2022;2022:hoac009. doi: 10.1093/hropen/hoac009
doi: 10.1093/hropen/hoac009
Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet Lond Engl 2021;397:839–852. doi: 10.1016/S0140-6736(21)00389-5
doi: 10.1016/S0140-6736(21)00389-5
Rzewuska N, Kunicki M, Mechsner S, Kordowitzki P. Rare clinical presentation of postmenopausal endometriosis: a new perspective. Aging Dis 2023. doi: 10.14336/AD.2023.1022
doi: 10.14336/AD.2023.1022
Snyder BM, Beets JW, Lessey BA, Horton SRW, Abrams GA. Postmenopausal deep infiltrating endometriosis of the colon: rare location and novel medical therapy. Case Rep Gastrointest Med 2018;2018:9587536. doi: 10.1155/2018/9587536
doi: 10.1155/2018/9587536
Sedati A, Mariani L, Giovinazzi R, Yacoub M, Atlante G. The effectiveness of danazol therapy in postmenopausal women affected by endometrial hyperplasia. Clin Exp Obstet Gynecol 1992;19:161–165.
Barbieri RL, Evans S, Kistner RW. Danazol in the treatment of endometriosis: analysis of 100 cases with a 4-year follow-up. Fertil Steril 1982;37:737–746. doi: 10.1016/s0015-0282(16)46331-4
doi: 10.1016/s0015-0282(16)46331-4
Farmer JE, Prentice A, Breeze A, et al. Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density. Cochrane Database Syst Rev 2003;2003:CD001297. doi: 10.1002/14651858.CD001297
doi: 10.1002/14651858.CD001297
Beaumont HH, Augood C, Duckitt K, Lethaby A. Danazol for heavy menstrual bleeding. Cochrane Database Syst Rev 2007;2007:CD001017. doi: 10.1002/14651858.CD001017.pub2
doi: 10.1002/14651858.CD001017.pub2
Bush TL, Whiteman M, Flaws JA. Hormone replacement therapy and breast cancer: a qualitative review. Obstet Gynecol 2001;98:498–508. doi: 10.1016/s0029-7844(01)01453-3
doi: 10.1016/s0029-7844(01)01453-3
Anderson GL, Limacher M, Assaf AR, et al; Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701–1712. doi: 10.1001/jama.291.14.1701
doi: 10.1001/jama.291.14.1701
Lyytinen H, Pukkala E, Ylikorkala O. Breast cancer risk in postmenopausal women using estrogen-only therapy. Obstet Gynecol 2006;108:1354–1360. doi: 10.1097/01.AOG.0000241091.86268.6e
doi: 10.1097/01.AOG.0000241091.86268.6e
Soliman NF, Hillard TC. Hormone replacement therapy in women with past history of endometriosis. Climacteric 2006;9:325–335. doi: 10.1080/13697130600868711
doi: 10.1080/13697130600868711
Chantalat E, Valera M-C, Vaysse C, et al. Estrogen Receptors and Endometriosis. Int J Mol Sci 2020;21:2815. doi: 10.3390/ijms21082815
doi: 10.3390/ijms21082815
Choi JK, Bae HA, Sang JH, Chung S-H. Postmenopausal spontaneous umbilical endometriosis: a case report. J Menopausal Med 2020;26:44–46. doi: 10.6118/jmm.19016
doi: 10.6118/jmm.19016
Martin KA, Manson JE. Approach to the patient with menopausal symptoms. J Clin Endocrinol Metab 2008;93:4567–4575. doi: 10.1210/jc.2008-1272
doi: 10.1210/jc.2008-1272
Santen RJ, Stuenkel CA, Yue W. Mechanistic effects of estrogens on breast cancer. Cancer J 2022;28:224–240. doi: 10.1097/PPO.0000000000000596
doi: 10.1097/PPO.0000000000000596
Chen F-P. Postmenopausal hormone therapy and risk of breast cancer. Chang Gung Med J 2009;32:140–147.
Manyonda I, Sinai Talaulikar V, Pirhadi R, Ward J, Banerjee D, Onwude J. Could perimenopausal estrogen prevent breast cancer? Exploring the differential effects of estrogen-only versus combined hormone replacement therapy. J Clin Med Res 2022;14:1–7. doi: 10.14740/jocmr4646
doi: 10.14740/jocmr4646
Shapiro S, Farmer RDT, Mueck AO, Seaman H, Stevenson JC. Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: part 2. The Women's Health Initiative: estrogen plus progestogen. J Fam Plann Reprod Health Care 2011;37:165–172. doi: 10.1136/jfprhc-2011-0090
doi: 10.1136/jfprhc-2011-0090
Chlebowski RT, Anderson GL, Aragaki AK, et al. Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the Women's Health Initiative randomized clinical trials. JAMA 2020;324:369–380. doi: 10.1001/jama.2020.9482
doi: 10.1001/jama.2020.9482
Pan K, Lavasani S, Aragaki AK, Chlebowski RT. Estrogen therapy and breast cancer in randomized clinical trials: a narrative review. Menopause 2022;29:1086–1092. doi: 10.1097/GME.0000000000002021
doi: 10.1097/GME.0000000000002021
Zanelotti A, DeCherney AH. Surgery and endometriosis. Clin Obstet Gynecol 2017;60:477–484. doi: 10.1097/GRF.0000000000000291
doi: 10.1097/GRF.0000000000000291
Somboonporn W, Panna S, Temtanakitpaisan T, Kaewrudee S, Soontrapa S. Effects of the levonorgestrel-releasing intrauterine system plus estrogen therapy in perimenopausal and postmenopausal women: systematic review and meta-analysis. Menopause 2011;18:1060–1066. doi: 10.1097/gme.0b013e31821606c5
doi: 10.1097/gme.0b013e31821606c5
Zanello M, Borghese G, Manzara F, et al. Hormonal replacement therapy in menopausal women with history of endometriosis: a review of literature. Medicina (Kaunas) 2019;55:477. doi: 10.3390/medicina55080477
doi: 10.3390/medicina55080477
Ozyurek ES, Yoldemir T, Kalkan U. Surgical challenges in the treatment of perimenopausal and postmenopausal endometriosis. Climacteric 2018;21:385–390. doi: 10.1080/13697137.2018.1439913
doi: 10.1080/13697137.2018.1439913
Carbonnel M, Goetgheluck J, Frati A, Even M, Ayoubi JM. Robot-assisted laparoscopy for infertility treatment: current views. Fertil Steril 2014;101:621–626. doi: 10.1016/j.fertnstert.2014.01.020
doi: 10.1016/j.fertnstert.2014.01.020
Moawad G, Youssef Y, Ayoubi JM, Feki A, De Ziegler D, Roman H. Diaphragmatic endometriosis: robotic approaches and techniques. Fertil Steril 2022;118:1194–1195. doi: 10.1016/j.fertnstert.2022.09.019
doi: 10.1016/j.fertnstert.2022.09.019
Afors K, Murtada R, Centini G, et al. Employing laparoscopic surgery for endometriosis. Womens Health 2014;10:431–443. doi: 10.2217/WHE.14.28
doi: 10.2217/WHE.14.28
Moen MH, Rees M, Brincat M, et al. European Menopause and Andropause Society, EMAS position statement: managing the menopause in women with a past history of endometriosis. Maturitas 2010;67:94–97. doi: 10.1016/j.maturitas.2010.04.018
doi: 10.1016/j.maturitas.2010.04.018
Gemmell LC, Webster KE, Kirtley S, Vincent K, Zondervan KT, Becker CM. The management of menopause in women with a history of endometriosis: a systematic review. Hum Reprod Update 2017;23:481–500. doi: 10.1093/humupd/dmx011
doi: 10.1093/humupd/dmx011
Polyzos NP, Fatemi HM, Zavos A, et al. Aromatase inhibitors in post-menopausal endometriosis. Reprod Biol Endocrinol RBE 2011;9:90. doi: 10.1186/1477-7827-9-90
doi: 10.1186/1477-7827-9-90
Nothnick WB. The emerging use of aromatase inhibitors for endometriosis treatment. Reprod Biol Endocrinol 2011;9:87. doi: 10.1186/1477-7827-9-87
doi: 10.1186/1477-7827-9-87
Takayama K, Zeitoun K, Gunby RT, Sasano H, Carr BR, Bulun SE. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil Steril 1998;69:709–713. doi: 10.1016/S0015-0282(98)00022-3
doi: 10.1016/S0015-0282(98)00022-3
Rannevik G. Hormonal, metabolic and clinical effects of danazol in the treatment of endometriosis. Postgrad Med J 1979;55(Suppl 5):14–20.
Selak V, Farquhar C, Prentice A, Singla A. Danazol for pelvic pain associated with endometriosis. Cochrane Database Syst. Rev 2007;4:CD000068. doi: 10.1002/14651858.CD000068.pub2
doi: 10.1002/14651858.CD000068.pub2
Maddern J, Grundy L, Castro J, Brierley SM. Pain in endometriosis. Front Cell Neurosci 2020;14:590823. doi: 10.3389/fncel.2020.590823
doi: 10.3389/fncel.2020.590823
Nezhat C, Vang N, Tanaka PP, Nezhat C. Optimal management of endometriosis and pain. Obstet Gynecol 2019;134:834–839. doi: 10.1097/AOG.0000000000003461
doi: 10.1097/AOG.0000000000003461
Brasky TM, Felix AS, Cohn DE, et al. Nonsteroidal anti-inflammatory drugs and endometrial carcinoma mortality and recurrence. JNCI J. Natl. Cancer Inst 2016;109:1–10. doi: 10.1093/jnci/djw251
doi: 10.1093/jnci/djw251
Tournaire M, Theau-Yonneau A. Complementary and alternative approaches to pain relief during labor. Evid-Based Complement Altern Med ECAM 2007;4:409–417. doi: 10.1093/ecam/nem012
doi: 10.1093/ecam/nem012
Evans S, Fernandez S, Olive L, Payne LA, Mikocka-Walus A. Psychological and mind-body interventions for endometriosis: a systematic review. J Psychosom Res 2019;124:109756. doi: 10.1016/j.jpsychores.2019.109756
doi: 10.1016/j.jpsychores.2019.109756
Thomsen LH, Schnack TH, Buchardi K, et al. Risk factors of epithelial ovarian carcinomas among women with endometriosis: a systematic review. Acta Obstet Gynecol Scand 2017;96:761–778. doi: 10.1111/aogs.13010
doi: 10.1111/aogs.13010
Metzemaekers J, Slotboom S, Sampat J, et al. Crossroad decisions in deep endometriosis treatment options: a qualitative study among patients. Fertil Steril 2021;115:702–714. doi: 10.1016/j.fertnstert.2020.06.041
doi: 10.1016/j.fertnstert.2020.06.041
Veth VB, de Kar M, Duffy JM, Wely M, Mijatovic V, Maas JW. Gonadotrophin-releasing hormone analogues for endometriosis. Cochrane Database Syst Rev 2021;2021:CD014788. doi: 10.1002/14651858.CD014788
doi: 10.1002/14651858.CD014788
Kumar P, Sharma A. Gonadotropin-releasing hormone analogs: understanding advantages and limitations. J Hum Reprod Sci 2014;7:170–174. doi: 10.4103/0974-1208.142476
doi: 10.4103/0974-1208.142476
Maggi R, Cariboni AM, Marelli MM, et al. GnRH and GnRH receptors in the pathophysiology of the human female reproductive system. Hum Reprod Update 2016;22:358–381. doi: 10.1093/humupd/dmv059
doi: 10.1093/humupd/dmv059
Acién P, Velasco I. Endometriosis: a disease that remains enigmatic. ISRN Obstet Gynecol 2013;2013:242149. doi: 10.1155/2013/242149
doi: 10.1155/2013/242149
Donnez J, Dolmans M-M. Endometriosis and medical therapy: from progestogens to progesterone resistance to GnRH antagonists: a review. J Clin Med 2021;10:1085. doi: 10.3390/jcm10051085
doi: 10.3390/jcm10051085
Kim JJ, Kurita T, Bulun SE. Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev 2013;34:130–162. doi: 10.1210/er.2012-1043
doi: 10.1210/er.2012-1043
Marquardt RM, Kim TH, Shin J-H, Jeong J-W. Progesterone and estrogen signaling in the endometrium: what goes wrong in endometriosis? Int J Mol Sci 2019;20:3822. doi: 10.3390/ijms20153822
doi: 10.3390/ijms20153822
Furness S, Roberts H, Marjoribanks J, Lethaby A. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database Syst Rev 2012;2012:CD000402. doi: 10.1002/14651858.CD000402.pub4
doi: 10.1002/14651858.CD000402.pub4
Flores VA, Vanhie A, Dang T, Taylor HS. Progesterone receptor status predicts response to progestin therapy in endometriosis. J Clin Endocrinol Metab 2018;103:4561–4568. doi: 10.1210/jc.2018-01227
doi: 10.1210/jc.2018-01227
Reis FM, Coutinho LM, Vannuccini S, Batteux F, Chapron C, Petraglia F. Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure. Hum Reprod Update 2020;26:565–585. doi: 10.1093/humupd/dmaa009
doi: 10.1093/humupd/dmaa009
Azeez JM, Susmi TR, Remadevi V, et al. New insights into the functions of progesterone receptor (PR) isoforms and progesterone signaling. Am. J. Cancer Res. 2021;11:5214–5232.
Mousazadeh S, Ghaheri A, Shahhoseini M, Aflatoonian R, Afsharian P. The effect of imbalanced progesterone receptor-A/-B ratio on gelatinase expressions in endometriosis. Int J Fertil Steril 2019;13:127–134. doi: 10.22074/ijfs.2019.5604
doi: 10.22074/ijfs.2019.5604
Monnin N, Fattet AJ, Koscinski I. Endometriosis: update of pathophysiology, (epi) genetic and environmental involvement. Biomedicine 2023;11:978. doi: 10.3390/biomedicines11030978
doi: 10.3390/biomedicines11030978
Patel BG, Rudnicki M, Yu J, Shu Y, Taylor RN. Progesterone resistance in endometriosis: origins, consequences and interventions. Acta Obstet Gynecol Scand 2017;96:623–632. doi: 10.1111/aogs.13156
doi: 10.1111/aogs.13156
Mitchell J-B, Chetty S, Kathrada F. Progestins in the symptomatic management of endometriosis: a meta-analysis on their effectiveness and safety. BMC Womens Health 2022;22:526. doi: 10.1186/s12905-022-02122-0
doi: 10.1186/s12905-022-02122-0
Zhang P, Wang G. Progesterone resistance in endometriosis: current evidence and putative mechanisms. Int J Mol Sci 2023;24:6992. doi: 10.3390/ijms24086992
doi: 10.3390/ijms24086992
Fedotcheva TA. Clinical use of progestins and their mechanisms of action: present and future (review). Mod Technol Med 2021;13:93–106. doi: 10.17691/stm2021.13.1.11
doi: 10.17691/stm2021.13.1.11
Sasson IE, Taylor HS. Stem Cells and the pathogenesis of endometriosis. Ann N Y Acad Sci 2008;1127:106–115. doi: 10.1196/annals.1434.014
doi: 10.1196/annals.1434.014
Figueira PGM, Abrão MS, Krikun G, Taylor H. Stem cells in endometrium and their role in the pathogenesis of endometriosis. Ann N Y Acad Sci 2011;1221:10–17. doi: 10.1111/j.1749-6632.2011.05969.x
doi: 10.1111/j.1749-6632.2011.05969.x
Sourial S, Tempest N, Hapangama DK. Theories on the pathogenesis of endometriosis. Int J Reprod Med 2014;2014:179515. doi: 10.1155/2014/179515
doi: 10.1155/2014/179515
Giannella L, Marconi C, Di Giuseppe J, et al. Malignant transformation of postmenopausal endometriosis: a systematic review of the literature. Cancer 2021;13:4026. doi: 10.3390/cancers13164026
doi: 10.3390/cancers13164026
Jia S-Z, Leng J-H, Shi J-H, Sun P-R, Lang J-H. Health-related quality of life in women with endometriosis: a systematic review. J Ovarian Res 2012;5:29. doi: 10.1186/1757-2215-5-29
doi: 10.1186/1757-2215-5-29
Marinho MCP, Magalhaes TF, Fernandes LFC, Augusto KL, Brilhante AVM, Bezerra LRPS. Quality of life in women with endometriosis: an integrative review. J Womens Health 2018;2002:399–408. doi: 10.1089/jwh.2017.6397
doi: 10.1089/jwh.2017.6397
Sheng J, Liu S, Wang Y, Cui R, Zhang X. The link between depression and chronic pain: neural mechanisms in the brain. Neural Plast 2017;2017:9724371. doi: 10.1155/2017/9724371
doi: 10.1155/2017/9724371
Barbara G, Buggio L, Facchin F, Vercellini P. Medical treatment for endometriosis: tolerability, quality of life and adherence. Front Glob Womens Health 2021;2:729601. doi: 10.3389/fgwh.2021.729601
doi: 10.3389/fgwh.2021.729601
Culley L, Law C, Hudson N, et al. The social and psychological impact of endometriosis on women's lives: a critical narrative review. Hum Reprod Update 2013;19:625–639. doi: 10.1093/humupd/dmt027
doi: 10.1093/humupd/dmt027
Della Corte L, Di Filippo C, Gabrielli O, et al. The burden of endometriosis on women's lifespan: a narrative overview on quality of life and psychosocial wellbeing. Int J Environ Res Public Health 2020;17:4683. doi: 10.3390/ijerph17134683
doi: 10.3390/ijerph17134683
Bloski T, Pierson R. Endometriosis and chronic pelvic pain. Nurs Womens Health 2008;12:382–395. doi: 10.1111/j.1751-486X.2008.00362.x
doi: 10.1111/j.1751-486X.2008.00362.x
Laganà AS, La Rosa VL, Rapisarda AMC, et al. Anxiety and depression in patients with endometriosis: impact and management challenges. Int J Womens Health 2017;9:323–330. doi: 10.2147/IJWH.S119729
doi: 10.2147/IJWH.S119729
Moorman PG, Schildkraut JM, Iversen ES, et al. A prospective study of weight gain after premenopausal hysterectomy. J Womens Health 2009;18:699–708. doi: 10.1089/jwh.2008.1019
doi: 10.1089/jwh.2008.1019
Yoldemir T. Quality of life for women with endometriosis: premenopausal and postmenopausal perspectives. Climacteric 2018;21:411–412. doi: 10.1080/13697137.2018.1511344
doi: 10.1080/13697137.2018.1511344
Haas D, Wurm P, Schimetta W, et al. Endometriosis patients in the postmenopausal period: pre- and postmenopausal factors influencing postmenopausal health. Biomed Res Int 2014;2014:e746705. doi: 10.1155/2014/746705
doi: 10.1155/2014/746705
Moradi M, Parker M, Sneddon A, Lopez V, Ellwood D. Impact of endometriosis on women's lives: a qualitative study. BMC Womens Health 2014;14:123. doi: 10.1186/1472-6874-14-123
doi: 10.1186/1472-6874-14-123
Missmer SA, Tu FF, Agarwal SK, et al. Impact of endometriosis on life-course potential: a narrative review. Int J Gen Med 2021;14:9–25. doi: 10.2147/IJGM.S261139
doi: 10.2147/IJGM.S261139
Di Donato N, Montanari G, Benfenati A, et al. Do women with endometriosis have to worry about sex? Eur J Obstet Gynecol Reprod Biol 2014;179:69–74. doi: 10.1016/j.ejogrb.2014.05.022
doi: 10.1016/j.ejogrb.2014.05.022
Alizadeh A, Farnam F. Coping with dyspareunia, the importance of inter and intrapersonal context on women's sexual distress: a population-based study. Reprod Health 2021;18:161. doi: 10.1186/s12978-021-01206-8
doi: 10.1186/s12978-021-01206-8
Scavello I, Maseroli E, Di Stasi V, Vignozzi L. Sexual health in menopause. Medicina (Mex) 2019;55:559. doi: 10.3390/medicina55090559
doi: 10.3390/medicina55090559
Faubion SS, Kuhle CL, Shuster LT, Rocca WA. Long-term health consequences of premature or early menopause and considerations for management. Climacteric J. Int. Menopause Soc. 2015;18:483–491. doi: 10.3109/13697137.2015.1020484
doi: 10.3109/13697137.2015.1020484
Pirtea P, de Ziegler D, Ayoubi JM. Effects of endometriosis on assisted reproductive technology: gone with the wind. Fertil Steril 2021;115:321–322. doi: 10.1016/j.fertnstert.2020.08.1431
doi: 10.1016/j.fertnstert.2020.08.1431
de Ziegler D, Pirtea P, Carbonnel M, et al. Assisted reproduction in endometriosis. Best Pract Res Clin Endocrinol Metab 2019;33:47–59. doi: 10.1016/j.beem.2018.10.001
doi: 10.1016/j.beem.2018.10.001
Pirtea P, Vulliemoz N, de Ziegler D, Ayoubi JM. Infertility workup: identifying endometriosis. Fertil Steril 2022;118:29–33. doi: 10.1016/j.fertnstert.2022.03.015
doi: 10.1016/j.fertnstert.2022.03.015
Marie-Scemama L, Even M, De La Joliniere JB, Ayoubi J-M. Endometriosis and the menopause: why the question merits our full attention. Horm. Mol. Biol. Clin. Investig 2019;37. doi: 10.1515/hmbci-2018-0071
doi: 10.1515/hmbci-2018-0071
Van Gorp T, Amant F, Neven P, Vergote I, Moerman P. Endometriosis and the development of malignant tumours of the pelvis. A review of literature. Best Pract Res Clin Obstet Gynaecol 2004;18:349–371. doi: 10.1016/j.bpobgyn.2003.03.001
doi: 10.1016/j.bpobgyn.2003.03.001
L.A. Brinton, G. Gridley, I. Persson, J. Baron, A. Bergqvist. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 176 (1997) 572–579. doi: 10.1016/s0002-9378(97)70550-7.
doi: 10.1016/s0002-9378
Farland LV, Harris HR. Long-term health consequences of endometriosis — pathways and mediation by treatment. Curr. Obstet. Gynecol. Rep. 2020;9:79–88. doi: 10.1007/s13669-020-00287-9
doi: 10.1007/s13669-020-00287-9
Poeta do Couto C, Policiano C, Pinto FJ, Brito D, Caldeira D. Endometriosis and cardiovascular disease: a systematic review and meta-analysis. Maturitas 2023;171:45–52. doi: 10.1016/j.maturitas.2023.04.001
doi: 10.1016/j.maturitas.2023.04.001
Shigesi N, Kvaskoff M, Kirtley S, et al. The association between endometriosis and autoimmune diseases: a systematic review and meta-analysis. Hum Reprod Update 2019;25:486–503. doi: 10.1093/humupd/dmz014
doi: 10.1093/humupd/dmz014
Salliss ME, Farland LV, Mahnert ND, Herbst-Kralovetz MM. The role of gut and genital microbiota and the estrobolome in endometriosis, infertility and chronic pelvic pain. Hum Reprod Update 2021;28:92–131. doi: 10.1093/humupd/dmab035
doi: 10.1093/humupd/dmab035
Kobayashi H. Gut and reproductive tract microbiota: insights into the pathogenesis of endometriosis (review). Biomed Rep 2023;19:43. doi: 10.3892/br.2023.1626
doi: 10.3892/br.2023.1626
Zizolfi B, Foreste V, Gallo A, Martone S, Giampaolino P, Di Spiezio Sardo A. Endometriosis and dysbiosis: state of art. Front Endocrinol (Lausanne) 2023;14:1140774. https://www.frontiersin.org/articles/10.3389/fendo.2023.1140774. Accessed June 3, 2023.
doi: 10.3389/fendo.2023.1140774.
Dothard MI, Allard SM, Gilbert JA. The effects of hormone replacement therapy on the microbiomes of postmenopausal women. Climacteric 2023;26:182–192. doi: 10.1080/13697137.2023.2173568
doi: 10.1080/13697137.2023.2173568
Dupuit M, Rance M, Morel C, et al. Effect of concurrent training on body composition and gut microbiota in postmenopausal women with overweight or obesity. Med Sci Sports Exerc 2022;54:517–529. doi: 10.1249/MSS.0000000000002809
doi: 10.1249/MSS.0000000000002809
Yoon K, Kim N. Roles of sex hormones and gender in the gut microbiota. J Neurogastroenterol Motil 2021;27:314–325. doi: 10.5056/jnm20208
doi: 10.5056/jnm20208
Baker JM, Al-Nakkash L, Herbst-Kralovetz MM. Estrogen-gut microbiome axis: physiological and clinical implications. Maturitas 2017;103:45–53. doi: 10.1016/j.maturitas.2017.06.025
doi: 10.1016/j.maturitas.2017.06.025
Yang M, Wen S, Zhang J, Peng J, Shen X, Xu L. Systematic review and meta-analysis: changes of gut microbiota before and after menopause. Dis Markers 2022;2022:3767373. doi: 10.1155/2022/3767373
doi: 10.1155/2022/3767373